Welcome to this UK AstraZeneca produced and funded website

This website is intended for UK Healthcare Professionals only.

 

The website contains both promotional and non-promotional content.

 

If you are a patient or a carer of a patient prescribed an AstraZeneca product, please visit myazmed.co.uk

 

For any other UK residents please visit astrazeneca.co.uk

I am not a Healthcare Professional
Prescribing information WAINZUA®▼(eplontersen)
Adverse Event Reporting

This website is intended for UK Healthcare Professionals only. Other UK residents please visit astrazeneca.co.uk

AstraZeneca-logo
  • Our Medicines
    • Cardiovascular, Renal & Metabolism
      • ATTR Amyloidosis
        • WAINZUA®▼(eplontersen)
      • Chronic Kidney Disease (CKD)
        • FORXIGA® (dapagliflozin)
      • Heart Failure
        • FORXIGA® (dapagliflozin)
      • Hyperkalaemia
        • LOKELMA® (sodium zirconium cyclosilicate)
      • Type 2 Diabetes (T2D)
        • FORXIGA® (dapagliflozin)
    • Oncology
      • Breast Cancer
        • LYNPARZA® (olaparib)
        • TRUQAP®▼(capivasertib)
      • Bladder Cancer
        • IMFINZI® (durvalumab)
      • Endometrial Cancer
        • IMFINZI® (durvalumab)
        • LYNPARZA® (olaparib)
      • Gastrointestinal Cancer
        • IMFINZI® (durvalumab)
        • IMJUDO®▼(tremelimumab)
      • Lung Cancer
        • IMFINZI® (durvalumab)
        • TAGRISSO® (osimertinib)
      • Ovarian Cancer
        • LYNPARZA® (olaparib)
      • Prostate Cancer
        • LYNPARZA® (olaparib)
        • ZOLADEX® (goserelin)
    • Respiratory
      • Asthma
        • TEZSPIRE®▼ (tezepelumab)
        • SYMBICORT® (budesonide/formoterol)
      • Chronic Obstructive Pulmonary Disease(COPD)
        • TRIXEO AEROSPHERE® (formoterol fumarate dihydrate/glycopyrronium/budesonide)
        • BEVESPI® (glycopyrronium/formoterol fumarate dihydrate)
    • Vaccines
      • Flu
        • FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
  • Therapy Areas
    • Cardiovascular, Renal & Metabolism
      • ATTR Amyloidosis
      • Chronic Kidney Disease (CKD)
      • Heart Failure
      • Hyperkalaemia
      • Type 2 Diabetes (T2D)
    • Oncology
      • Breast Cancer
      • Bladder Cancer
      • Endometrial Cancer
      • Gastrointestinal Cancer
      • Lung Cancer
      • Ovarian Cancer
      • Prostate Cancer
    • Respiratory
      • Asthma
      • Chronic Obstructive Pulmonary Disease(COPD)
    • Vaccines
      • Flu
  • About us
    • AZ Commitment
  • Contact us
  • AstraZeneca UK
  • WAINZUA® (eplontersen)
  • Patient Support
  • Welcome to WAINZUA
  • About ATTR Amyloidosis
  • Why WAINZUA
    • Mechanism of Action
    • Efficacy
    • Safety
  • Dosing & Administration
  • Patient Support
  • Resources
Acapella Patient support Programme (PSP)

WAINZUA logo

Acapella Patient Support Programme (PSP)

The Acapella PSP is initiated, managed and funded by AstraZeneca UK, and is designed to provide holistic support to patients, helping them navigate their treatment journey and manage their condition effectively. The service is offered free of charge to the NHS and patients prescribed WAINZUA within its licensed indication.

Patients can sign up to the Acapella PSP and access a range of educational resources about ATTR amyloidosis, as well as access personalised support for treatment with WAINZUA hosted on the Acapella website, including:

About ATTR amyloidosis

The different types of ATTR amyloidosis and symptoms.

What to expect

Management approaches for ATTR amyloidosis.

Life with amyloidosis

Lifestyle changes that can support daily living.

Support for patients

Access to wider support resources.

About treatment

How to use WAINZUA and adverse events.

Upon signing up to the PSP, your patient will have access to specialist services and be able to book appointments with the PSP healthcare team, including:

Apple with stem and leaf Apple with stem and leaf


Dietitians

Physiotherapist aiding patient in walking Physiotherapist aiding patient in walking


Physiotherapists

Brain with gears in one hemisphere, heart icon in the other Brain with gears in one hemisphere, heart icon in the other


Counsellors

Phone Phone


Nurse Care Coordinators

Patients can also be given a patient-facing guide after their appointment to support their use of the PSP.

 

For more information, please watch the Acapella PSP video or download the Acapella PSP infographic below.

 

Acapella PSP video

Watch this video to learn more about the Acapella Patient Support Programme, including available patient resources, who the Acapella healthcare team is and how to support your patients receiving WAINZUA in signing up. The Acapella PSP is available only to eligible patients who enroll in the programme and are prescribed WAINZUA.

 

 

Watch the video

 

Acapella PSP infographic

Learn more about how your patients receiving WAINZUA can access additional support (including dietary support, counselling, physiotherapy and on-demand nurse care), via the Acapella PSP. The Acapella PSP is available only to eligible patients who enroll in the programme and are prescribed WAINZUA.



 

Download

 

Scan here

Your patients can scan the QR code or visit www.acapellapsp.com to sign up to the Acapella PSP.
 
By scanning the QR code or clicking on the link you will be redirected to another AstraZeneca owned and funded website for patients.

Green and gold outlines of people

Contact us

If you have any questions about WAINZUA or would like to speak to an AstraZeneca representative, please contact us.

Contact options

ATTR=transthyretin amyloidosis; ATTRv-PN=transthyretin amyloidosis with polyneuropathy; PSP=Patient Support Programme; NHS=National Health Service.

GB-73315 | Feburary 2026

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com/ or by calling ‌‌‌0‌‌‌8‌‌‌‌‌0‌‌‌‌0‌‌‌ ‌‌7‌‌‌‌‌‌8‌‌‌3‌‌‌ ‌‌0‌‌‌‌‌0‌‌‌‌3‌‌‌‌3‌‌‌.

AstraZeneca logo

This website was created for UK HCPs and has been designed to provide information to educate, empower and enable them in the great work they are doing for patients across a range of therapy areas. This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.

Terms of use

Privacy Policy

Cookie Policy

Contact Us

LinkedIn

Twitter

©2024 AstraZeneca. GB-69203 | November 2025